Viking Therapeutics adds Dorothy Gemmell to its board of directors

Go back to Viking Therapeutics adds Dorothy Gemmell to its board of directors
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 29.36 -0.16 (0.54%)
Previous Close $29.52    52 Week High $5.17 
Open $30.24    52 Week Low $0.94 
Day High $30.54    P/E N/A 
Day Low $29.26    EPS $0.00 
Volume 2,086,648